publication date: Mar. 24, 2017

Conversation with the Cancer Letter Rick Klausner: This is a profoundly disturbing statement about dramatically de-prioritizing research, science, and biomedical research

Rick Klausner currentPresident’s Donald Trump’s budget proposal should be treated as a genuine, credible threat to science, said Richard Klausner, a biotechnology entrepreneur who led NCI through the years of the doubling of the NIH budget.

“It is of concern not just because of numbers, but because of what it says about priorities and philosophy,” Klausner said.

Klausner spoke with Paul Goldberg, editor and publisher of The Cancer Letter.

 

Paul Goldberg:

Rick, what do you think of the president’s budget proposal?

Richard Klausner:

Well, there were so many things to dislike and to worry about.

But specifically, the proposed nearly 20 -percent cut for the NIH, I’m sure you’ve heard this from everyone: it would, in fact, be devastating to the NIH, but more importantly, to one of the things that does make America great, which is our scientific and biomedical enterprise, which is the envy of the world, and it’s the best. And this would be devastating to it. With consequences way beyond a one-year budget pullback.

Obviously, most … Continue reading Rick Klausner: This is a profoundly disturbing statement about dramatically de-prioritizing research, science, and biomedical research

To access this members-only content, please log in.
If you're not a subscriber why not join today?
If you believe you should be able to view this area but cannot log in, then please contact us and we will try to rectify this issue as soon as possible.
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2017 The Cancer Letter Inc.